市场调查报告书
商品编码
1470564
细胞增殖市场:按产品、细胞类型、应用和最终用户 - 2024-2030 年全球预测Cell Expansion Market by Product (Consumables, Instruments), Cell Type (Animal Cells, Human Cells), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
细胞增殖市场规模预估2023年为193.6亿美元,2024年达209亿美元,预估2030年将达337亿美元,复合年增长率为8.23%。
细胞增殖是指从少量的初始群体中培养大量的细胞。该程序是生物技术各领域的基础,包括药物开发、再生医学和临床研究。该过程涉及在受控条件下培养细胞并增加其数量,同时保持特定的特性和功能。细胞增殖对于确保研究人员和临床医生拥有足够数量的细胞用于治疗应用、研究或进一步的生物製造过程至关重要。细胞培养技术、反应器和自动化方面的创新提高了细胞生长过程的可扩展性和效率。全球糖尿病、癌症和心血管疾病盛行率的不断上升正在推动对再生疗法和生物製药的需求,从而推动细胞增殖市场的成长。然而,与细胞生长设备和消耗品相关的成本对市场成长构成了挑战。对个人化医疗和患者特异性治疗的日益关注正在为细胞增殖市场创造成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 193.6亿美元 |
预测年份 [2024] | 209亿美元 |
预测年份 [2030] | 337亿美元 |
复合年增长率(%) | 8.23% |
产品:由于在研究和生物製药製造中必须重复使用,因此扩大了细胞增殖消耗品的使用
消耗品是指在细胞生长过程中定期使用和更换的产品,例如试剂、培养基、血清和一次性反应器系统。这些材料对于试管内细胞的维持和生长至关重要。抛弃式是指一次性物品,例如旨在防止污染并确保细胞生长的无菌环境的烧瓶、板和管子。这些对于在细胞生长过程中维持细胞培养完整性至关重要。培养基是指细胞生长和增殖所需的富含营养的溶液。培养基必须精心配製,以满足目标细胞群的特定需求,确保最佳的生长结果。试剂促进细胞生长所需的生物反应和过程,例如分化和增殖。血清提供必需的生长因子、荷尔蒙和营养物质并支持细胞生长。儘管无血清培养基往往在更受控的条件下使用,但血清对于许多细胞类型仍然很重要。细胞生长涉及的设备包括该过程必需的硬体和设备,例如反应器、细胞培养容器和离心机。这些设备促进细胞生长所需的受控环境,并确保维持最佳生长的精确条件。自动化细胞扩增系统可提供更高的精度和控制,从而实现可扩展的细胞扩增,同时减少劳动力并降低污染风险。该系统是细胞培养领域的重要技术进步。微载体反应器利用微载体为悬浮培养中贴壁细胞的生长提供表面,促进受控环境中的大规模细胞生长。灌注或中空纤维反应器透过连续向培养物添加新鲜培养基并移除废弃物,维持最佳生长条件并生长緻密的细胞群。细胞计数器和血球计数器对于监测细胞密度和活力至关重要。这些工具确保增殖以所需的速度发生,并且细胞在整个过程中保持健康。离心机用于将细胞与培养基和其他溶液分离。离心机对于细胞扩增工作流程中的细胞收穫和下游处理至关重要。流式细胞仪提供细胞群的详细分析,包括活力、纯度和表型特征,确保扩增细胞的品质和一致性。
应用:L在再生医学、全球再生治疗干细胞研究的扩展
细胞增殖透过促进肿瘤生长动力学和各种药物对癌细胞影响的研究,在癌症和细胞研究中发挥至关重要的作用。此应用对于识别潜在的癌症治疗方法和了解细胞层面的癌症生物学至关重要,并描述了开发更有效治疗方法的途径。在再生医学和干细胞研究领域,细胞增殖对于产生足够数量的细胞用于组织再生和修復等治疗应用至关重要。透过利用干细胞的力量来替换或修復受损的组织和器官,这个过程支持开发多种疾病(包括退化性疾病)的治疗方法,并加速个人化医疗的进步。
区域洞察
美国凭藉其强大的生物技术和製药行业、对研发 (R&D) 的大量投资以及行业领先参与企业的强大影响力,在美洲细胞增殖市场中占据主导地位。该地区在研究和治疗应用方面对尖端技术的采用率很高,例如自动化细胞生长系统和反应器。加拿大和巴西细胞增殖市场的良好成长归因于政府对医学研究的资助增加、需要细胞治疗的慢性疾病盛行率上升以及对干细胞研究和治疗开发的监管支持。由于经济成长、医疗保健支出增加以及对生物技术研究的日益关注,亚太地区正在成为细胞增殖市场的一个充满活力的地区。中国、日本、韩国和澳洲等国家处于领先地位,在干细胞研究和再生医学方面投入大量资金。中国细胞增殖的显着增长是由政府加强生物技术研究的努力所推动的。日本强大的製药业和有利的再生医学法规环境为该地区该领域的市场开拓提供了重大进展。欧洲/中东/非洲地区呈现出多元化的市场格局,欧洲技术进步、研发活动和细胞治疗方法的采用都取得了重大进展。德国、英国和法国是重要的贡献者,并得到了有利的政府政策、广泛的研究基础设施以及学术界和工业界之间的合作的支持。由于生物技术研究活动的增加、医疗基础设施投资的增加以及需要先进治疗方法的慢性病盛行率的增加,非洲地区的细胞增殖市场正在不断增长。
FPNV定位矩阵
FPNV定位矩阵对于评估细胞增殖市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对细胞增殖市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、碎片化主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动和突破性产品开发的智力见解。
1. 细胞增殖市场的市场规模与预测是多少?
2.在细胞增殖市场的预测期内,我们应该考虑投资哪些产品和应用?
3. 细胞增殖市场的技术趋势和法规结构是什么?
4.细胞增殖市场主要厂商的市场占有率是多少?
5. 进入细胞增殖市场的合适形式和策略手段是什么?
[197 Pages Report] The Cell Expansion Market size was estimated at USD 19.36 billion in 2023 and expected to reach USD 20.90 billion in 2024, at a CAGR 8.23% to reach USD 33.70 billion by 2030.
Cell expansion refers to cultivating a large number of cells from a small initial population. This procedure is fundamental to various fields within biotechnology, including drug development, regenerative medicine, and clinical research. The process involves cultivating cells under controlled conditions to increase their number while maintaining their specific characteristics or functionality. Cell expansion is crucial in enabling researchers and clinicians to have sufficient quantities of cells for therapeutic applications, research studies, or further biological manufacturing processes. The innovations in cell culture technologies, bioreactors, and automation have improved the scalability and efficiency of cell expansion processes. The growing incidence of diabetes, cancer, and cardiovascular diseases globally drives demand for regenerative therapies and biopharmaceuticals, fueling the growth of the cell expansion market. However, the expenses associated with cell expansion instruments and consumables challenges the market growth. The increasing focus on personalized medicine and patient-specific treatments offers opportunities for the growth of the cell expansion market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.36 billion |
Estimated Year [2024] | USD 20.90 billion |
Forecast Year [2030] | USD 33.70 billion |
CAGR (%) | 8.23% |
Product: Expanding use of consumables in cell expansion due to their essential, repetitive use in research and biopharmaceutical production
Consumables refer to products such as reagents, media, sera, and disposable bioreactor systems that are regularly used and replaced throughout the cell expansion. These materials are crucial for the maintenance and proliferation of cells in vitro. Disposables are single-use items such as flasks, plates, and tubes designed to prevent contamination and ensure a sterile environment for cell growth. They are crucial for maintaining the integrity of cell cultures during the expansion process. Media refers to the nutrient-rich solutions required for cell growth and proliferation. Media must be carefully formulated to meet the specific needs of the target cell population, ensuring optimal expansion outcomes. Reagents facilitate biological reactions and processes necessary for cell growth, such as differentiation and proliferation. Sera provides essential growth factors, hormones, and nutrients that support cell expansion. Despite the trend towards serum-free media for more controlled conditions, sera remains crucial for many cell types. Instruments in cell expansion encompass the hardware and devices essential for the process, including bioreactors, cell culture vessels, and centrifuges. These instruments facilitate the controlled environment necessary for cell growth, ensuring precise conditions are maintained for optimal expansion. Automated cell expansion systems offer higher precision and control, enabling scalable cell expansion with reduced labor and a lower risk of contamination. They represent an essential technological advancement in the field of cell culture. Microcarrier bioreactors utilize microcarriers that provide a surface for adherent cells to grow in a suspended culture, facilitating large-scale cell expansion in a controlled environment. Perfusion or hollow fiber bioreactors operate by continuously feeding fresh media into the culture while removing waste, maintaining optimal growth conditions and expanding high-density cell populations. Cell counters & hemocytometers are essential for monitoring cell density and viability; these tools ensure that expansion proceeds at the desired pace and that cells remain healthy throughout the process. Centrifuges are used to separate cells from media and other solutions; centrifuges are vital for cell harvesting and downstream processing in the expansion workflow. Flow cytometers provide detailed analysis of cell populations, including viability, purity, and phenotypic characteristics, ensuring the quality and consistency of expanded cells.
Application: ell expansion in regenerative medicine & stem cell research for regenerative treatments globally
In cancer and cell-based research, cell expansion plays a pivotal role by facilitating the study of tumor growth kinetics and the effects of various drugs on cancer cells. This application is critical for identifying potential cancer treatments and understanding cancer biology at a cellular level, thus offering a pathway toward developing more effective therapies. Within regenerative medicine and stem cell research, cell expansion is indispensable for generating sufficient quantities of cells required for therapeutic applications, such as tissue regeneration and repair. This process supports the development of treatments for various conditions, including degenerative diseases, by harnessing the power of stem cells to replace or repair damaged tissues and organs, furthering the advancement of personalized medicine.
Regional Insights
The United States dominates the cell expansion market in the Americas due to its robust biotechnology and pharmaceutical sectors, significant investments in research and development (R&D), and strong presence of leading industry players. The region witnesses a high adoption rate of advanced technologies, including automated cell expansion systems and bioreactors, catering to research and therapeutic applications. The promising growth of the cell expansion market in Canada and Brazil can be attributed to increased government funding for healthcare research, the rising prevalence of chronic diseases requiring cell therapy treatments, and regulatory support for stem cell research and therapy development. The Asia-Pacific region is emerging as a dynamic area in the cell expansion market, driven by economic growth, growing healthcare expenditure, and an increasing focus on biotechnology research. Countries like China, Japan, South Korea, and Australia are at the forefront, investing significantly in stem cell research and regenerative medicine. China's significant growth in cell expansion is propelled by governmental efforts to enhance biotechnology research. Japan's robust pharmaceutical sector and favorable regulatory environment for regenerative medicine majorly advance the region's market development in this field. The EMEA region showcases a diverse landscape for the cell expansion market, with Europe showcasing significant technological advancement, R&D activities, and adoption of cell-based therapies. Germany, the United Kingdom, and France are vital contributors, supported by favorable government policies, extensive research infrastructure, and collaborations between academia and industry. The cell expansion market in the African region is growing, driven by increasing research activities in biotechnology, rising investments in healthcare infrastructure, and the growing prevalence of chronic diseases requiring advanced therapeutic approaches.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cell Expansion Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Expansion Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cell Expansion Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Techne Corporation, Celltainer Biotech B.V., Corning Incorporated, Cytiva, Danaher Corporation, Eppendorf SE, G&G Technologies, Inc., GE Healthcare, iXCells Biotechnologies, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Neuromics, NexImmune, Novartis AG, PromoCell GmbH, REPROCELL Inc., Sartorius AG, Scinus Cell Expansion, Stemcell Technologies, Inc., Takara Bio Inc., Terumo BCT, TERUMO BCT, INC., and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Cell Expansion Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Expansion Market?
3. What are the technology trends and regulatory frameworks in the Cell Expansion Market?
4. What is the market share of the leading vendors in the Cell Expansion Market?
5. Which modes and strategic moves are suitable for entering the Cell Expansion Market?
TABLE 3